Medlive Technology Issues 0.09% New Shares Following Director’s Option Exercise

Bulletin Express

Apr 09

Medlive Technology Co., Ltd. (Medlive) disclosed a minor expansion of its share capital after a director exercised Pre-IPO share options granted under the 29 March 2021 scheme.

• Scale of issuance: 700,000 ordinary shares were issued on 9 April 2026, equivalent to 0.09% of Medlive’s pre-event issued share base.

• Issue price: RMB 0.38 per share, as specified in the option terms.

• Share capital impact: The total number of issued shares increased from 739.26 million to 739.96 million.

• Treasury shares: The company held no treasury shares before or after the transaction, and there were no share repurchases or cancellations outstanding.

The board affirmed that the issuance complied with all Hong Kong Stock Exchange listing rules and relevant legal requirements, and confirmed full receipt of funds due from the option exercise.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1165255587"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165255587\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165255587?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-09 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165255587","market":"us","top_or_hot":-1,"title":"Medlive Technology Issues 0.09% New Shares Following Director’s Option Exercise","media":"Bulletin Express","content":"<p>Medlive Technology Co., Ltd. (Medlive) disclosed a minor expansion of its share capital after a director exercised Pre-IPO share options granted under the 29 March 2021 scheme.</p>\n<p>• Scale of issuance: 700,000 ordinary shares were issued on 9 April 2026, equivalent to 0.09% of Medlive’s pre-event issued share base.</p>\n<p>• Issue price: RMB 0.38 per share, as specified in the option terms.</p>\n<p>• Share capital impact: The total number of issued shares increased from 739.26 million to 739.96 million.</p>\n<p>• Treasury shares: The company held no treasury shares before or after the transaction, and there were no share repurchases or cancellations outstanding.</p>\n<p>The board affirmed that the issuance complied with all Hong Kong Stock Exchange listing rules and relevant legal requirements, and confirmed full receipt of funds due from the option exercise.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medlive Technology Issues 0.09% New Shares Following Director’s Option Exercise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedlive Technology Issues 0.09% New Shares Following Director’s Option Exercise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-09 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medlive Technology Co., Ltd. (Medlive) disclosed a minor expansion of its share capital after a director exercised Pre-IPO share options granted under the 29 March 2021 scheme.</p>\n<p>• Scale of issuance: 700,000 ordinary shares were issued on 9 April 2026, equivalent to 0.09% of Medlive’s pre-event issued share base.</p>\n<p>• Issue price: RMB 0.38 per share, as specified in the option terms.</p>\n<p>• Share capital impact: The total number of issued shares increased from 739.26 million to 739.96 million.</p>\n<p>• Treasury shares: The company held no treasury shares before or after the transaction, and there were no share repurchases or cancellations outstanding.</p>\n<p>The board affirmed that the issuance complied with all Hong Kong Stock Exchange listing rules and relevant legal requirements, and confirmed full receipt of funds due from the option exercise.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02192","symbol_name":"医脉通","start_time":0,"source_url":"","article_id":"1165255587","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165255587","pubTimestamp":1775725408,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Medlive Technology Co., Ltd. (Medlive) disclosed a minor expansion of its share capital after a director exercised Pre-IPO share options granted under the 29 March 2021 scheme. • Scale of issuance:...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02192":"医脉通"},"translate_title":"Medlive Technology在董事期权行使后发行0.09%新股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02192":1},"content_text":"Medlive Technology Co., Ltd. (Medlive) disclosed a minor expansion of its share capital after a director exercised Pre-IPO share options granted under the 29 March 2021 scheme.\n• Scale of issuance: 700,000 ordinary shares were issued on 9 April 2026, equivalent to 0.09% of Medlive’s pre-event issued share base.\n• Issue price: RMB 0.38 per share, as specified in the option terms.\n• Share capital impact: The total number of issued shares increased from 739.26 million to 739.96 million.\n• Treasury shares: The company held no treasury shares before or after the transaction, and there were no share repurchases or cancellations outstanding.\nThe board affirmed that the issuance complied with all Hong Kong Stock Exchange listing rules and relevant legal requirements, and confirmed full receipt of funds due from the option exercise.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}